SNY - What's Going On With Mirati Therapeutics Stock? | Benzinga
Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares are trading higher Friday. Several analysts updated their price targets on the stock, and investors consider reports of a potential acquisition of the company.
What To Know:
Several analysts updated Mirati price targets on Friday:
- BMO Capital analyst Evan David Seigerman maintained Mirati Therapeutics with a ...